University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Hip Muscle Power, Lateral Balance Function, and Falls in Aging

Not Applicable

Active, not recruiting

Conditions: Accidental Falls

Interventions: Other: Strength Training
Other: Power Training

First Posted Date: 2018-11-06

Last Posted Date: 2024-10-17

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 100

Registration Number: NCT03731572

Locations: 🇺🇸
VA Maryland Health Care System, Baltimore, Maryland, United States

Blood Donor CVD 9000

Phase 4

Terminated

Conditions: Cholera Vaccination

Interventions: Drug: Vaxchora

First Posted Date: 2018-10-30

Last Posted Date: 2023-02-02

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 3

Registration Number: NCT03724357

Locations: 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera

Phase 4

Recruiting

Conditions: Typhoid and/or Cholera Vaccination

Interventions: Drug: Vivotif Typhoid Oral Vaccine
Drug: Vaxchora

First Posted Date: 2018-10-15

Last Posted Date: 2024-01-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 240

Registration Number: NCT03705585

Locations: 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

Hepatitis C Positive Donor Into Hepatitis C Negative Recipients

Early Phase 1

Withdrawn

Conditions: Hepatitis C

Interventions: Drug: Direct Acting Antivirals

First Posted Date: 2018-10-11

Last Posted Date: 2023-05-06

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03702218

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Neuromuscular and Biomechanical Control of Lower Limb Loading in Individuals With Chronic Stroke

Not Applicable

Completed

Conditions: Stroke
Hemiparesis

Interventions: Other: Conventional Training
Other: Limb Loading

First Posted Date: 2018-10-03

Last Posted Date: 2022-10-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 25

Registration Number: NCT03694028

Locations: 🇺🇸
PTRS Research Lab, Baltimore, Maryland, United States

Nicotinamide Riboside for Diabetic Neuropathy

Phase 1

Suspended

Conditions: Diabetic Neuropathy Peripheral

Interventions: Drug: Placebo
Drug: Niagen

First Posted Date: 2018-09-26

Last Posted Date: 2022-04-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 54

Registration Number: NCT03685253

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

Phase 1

Recruiting

Conditions: Locally Advanced Pancreatic Cancer

Interventions: Drug: Gemcitabine
Radiation: Hypofractionated Ablative Proton Therapy

First Posted Date: 2018-08-29

Last Posted Date: 2024-03-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 24

Registration Number: NCT03652428

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
University of Maryland Medical Center/Maryland Proton Treatment Center, Baltimore, Maryland, United States

SEEK: Dissemination and Implementation

Not Applicable

Active, not recruiting

Conditions: Child Maltreatment

Interventions: Other: Independent online training (IND)

First Posted Date: 2018-08-22

Last Posted Date: 2024-01-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 1100

Registration Number: NCT03642327

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed

Conditions: Acute Kidney Injury
Renal Insufficiency
Renal Failure
Pharmacokinetics

Interventions: Drug: Levetiracetam
Drug: Lacosamide
Drug: Phenytoin
Drug: Phenobarbital
Drug: Ketamine
Drug: Valproic Acid

First Posted Date: 2018-08-16

Last Posted Date: 2021-10-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 18

Registration Number: NCT03632915

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes

Phase 4

Withdrawn

Conditions: Heart Failure NYHA Class IV

Interventions: Drug: Placebos
Drug: Ivabradine

First Posted Date: 2018-08-15

Last Posted Date: 2024-12-12

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03631654

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy